Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Industry Assesses Threat From Drug-Pricing Debate

Executive Summary

Drug pricing and government oversight were raised as critical issues for the industry in panels, presentations and conversations throughout the BIO CEO & Investor conference, with opinions varying on how much of a threat it could be.

Advertisement

Related Content

At Drug Pricing Hearing, Innovator Companies Mainly Escape Congressional Wrath

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register